• 2791 Citations
  • 27 h-Index
1993 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Monica Balzarotti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 35 Similar Profiles
Lymphoma Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Cytarabine Medicine & Life Sciences
Methotrexate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

  • 2791 Citations
  • 27 h-Index
  • 93 Article
  • 1 Chapter

Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice

Broccoli, A., Casadei, B., Chiappella, A., Visco, C., Tani, M., Cascavilla, N., Conconi, A., Balzarotti, M., Cox, M. C., Marino, D., Goldaniga, M. C., Marasca, R., Tecchio, C., Patti, C., Musuraca, G., Devizzi, L., Monaco, F., Romano, A., Fama, A., Zancanella, M. & 6 others, Paolini, R., Rigacci, L., Castellino, C., Gaudio, F., Argnani, L. & Zinzani, P. L., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Multicenter Studies
Retrospective Studies
Non-Hodgkin's Lymphoma
Therapeutics

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

on behalf of the “Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup), Jan 1 2019, In : Hematological Oncology.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Virus Diseases
Hepacivirus
Multicenter Studies
Lymphoma

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

Rattotti, S., Ferretti, V. V., Rusconi, C., Rossi, A., Fogazzi, S., Baldini, L., Pioltelli, P., Balzarotti, M., Farina, L., Ferreri, A. J. M., Laszlo, D., Speziale, V., Varettoni, M., Sciarra, R., Morello, L., Tedeschi, A., Frigeni, M., Defrancesco, I., Zerbi, C., Flospergher, E. & 4 others, Nizzoli, M. E., Morra, E., Arcaini, L. & Workgroup), O. B. O. T. R. E. L. REL. . H. C. N. O. L. . L., 2019, In : Hematological Oncology. 37, 2, p. 160-167

Research output: Contribution to journalArticle

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., Feb 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Comorbidity
Stroke Volume
Doxorubicin
Preexisting Condition Coverage